Trials / Completed
CompletedNCT00063297
Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 180 (planned)
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study is to determine the efficacy (how well the drug works), safety, and side effects of the study medication compared to placebo in the treatment of the negative symptoms of schizophrenia in adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | R209130 |
Timeline
- Start date
- 2003-05-01
- Completion
- 2003-10-01
- First posted
- 2003-06-26
- Last updated
- 2009-08-28
Locations
29 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00063297. Inclusion in this directory is not an endorsement.